ProductProductWhat are Generics?
Lexapro
view photo
Generic Lexapro Escitalopram 5/10/20mg

Generic Lexapro is used for treating depression and generalized anxiety disorder.


Antidepressants


PackagePricePer pillSavingsOrder
5mg × 30 pills$44.95$ 1.50 
5mg × 60 pills$83.95$ 1.40  $5.95
5mg × 90 pills$116.95$ 1.30  $17.90
5mg × 120 pills$143.95$ 1.20  $35.85
5mg × 180 pills$179.95$ 1.00  $89.75
PackagePricePer pillSavingsOrder
10mg × 30 pills$50.95$ 1.70 
10mg × 60 pills$95.95$ 1.60  $5.95
10mg × 90 pills$134.95$ 1.50  $17.90
10mg × 120 pills$167.95$ 1.40  $35.85
10mg × 180 pills$233.95$ 1.30  $71.75
PackagePricePer pillSavingsOrder
20mg × 30 pills$59.95$ 2.00 
20mg × 60 pills$113.95$ 1.90  $5.95
20mg × 90 pills$161.95$ 1.80  $17.90
20mg × 120 pills$203.95$ 1.70  $35.85
20mg × 180 pills$269.95$ 1.50  $89.75
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
Yes! I have received the order and I am extremely pleased with the service and the pills. I had previously been paying a very high price through prescriptions from my local GP. I am now able to order online without hassle and delivery has been within the stated period that you give. Many thanks!
Read more »Read more »
NewsNews
    Generic competition for Lexapro/Cipralex hits Lundbeck's first-quarter - The Pharma Letter
    Generic competition for Lexapro/Cipralex hits Lundbeck's first-quarterThe Pharma LetterEBIT fell 32% to 882 million kroner, also shy of analysts' expectations of 895 million kroner, as the company faced generic competition for its flagship antidepressant Cipralex/Lexapro (escitalopram), which is sold by Forest Labs in the USA
    Lundbeck Gains Amid Speculation of Antidepressant Success - BusinessWeek
    Lundbeck Gains Amid Speculation of Antidepressant SuccessBusinessWeekBy Christian Wienberg on May 21, 2012 H
    Lundbeck keeps year outlook after Q1 lags forecasts - Reuters
    Lundbeck keeps year outlook after Q1 lags forecastsReuters* Q1 EBIT 882 mln DKK vs average forecast 925 mln * Keeps 2012 profit, revenue guidance * Says revenue grew when discounting Lexapro revenue COPENHAGEN, May 2 (Reuters) - Danish drugmaker Lundbeck stood by its forecasts for 2012 on Wednesday despite a
    Lundbeck Sees Lower Libido Risk With New Antidepressant - Bloomberg
    Lundbeck Sees Lower Libido Risk With New AntidepressantBloombergIt will help Lundbeck, the Nordic region's second-largest drugmaker, replace lost revenue from its best-selling Lexapro antidepressant, which went off- patent in the US in March
    Lundbeck buoyed by data on new antidepressant - PMLiVE
    Lundbeck buoyed by data on new antidepressantPMLiVELundbeck has reported positive phase III data on LU AA21004, a new antidepressant that could help it cope with the impact of generic competition to flagship product Cipralex/Lexapro
Live support Online Chat


Our billing is certified by
Secure shopping certificates